Anne Rancourt Named Director of Health Communication at FDA CTP

News by 2FIRSTS.ai

Apr.10.2024

Anne Rancourt Named Director of Health Communication at FDA CTP

Anne Rancourt named next director of CTP's Health Communication and Education Office by FDA, effective May 19.

The U.S. Food and Drug Administration (FDA) subsidiary Tobacco Products Center (CTP) recently announced that Anne Rancourt has been selected as the next director of the Office of Health Communication and Education. Rancourt previously served as the Communications Director at the National Institute on Drug Abuse (NIDA) at the National Institutes of Health (NIH).

Lungkul has over 20 years of experience in strategic communications, behavior change projects, and news fields, including nearly 14 years of work in the federal government. She managed the communication department at NIDA, overseeing the dissemination of research findings on substance use and addiction worth nearly $2 billion, including tobacco and e-cigarette use. Prior to this, she also served as the Chief of Communications Science at the National Institute of Allergy and Infectious Diseases (NIAID).

CTP stated that Lankhul has been selected after undergoing a thorough nationwide search and passing the important ethical and safety review process by the FDA. She will take office on May 19th.

Also Read:

[1] Turning Point Brands Appoints Andrew Flynn as Chief Financial Officer

[2] PMI Appoints Christos Harpantidis as Senior Vice President

[3] KT&G CEO Appointment Uncertainty: Largest Shareholder Opposing

[4] Aziz Aliev Appointed as New General Manager of BAT Austria

#North America #United States #Traditional tobacco #FDA #Major companies

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn

Notice

1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

Copyright

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

AI Assistance Disclaimer

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Product | ON! PLUS: Breakdown of Six FDA-PMTA-Authorized Nicotine Pouches—6/9 mg Strengths, Slim Format, and Traditional Flavours

The U.S. FDA has added six ON!® PLUS nicotine pouch products to its list of Marketing Granted Order (MGO) authorizations. Based on 2Firsts’ review, the approved products feature a highly standardized configuration in terms of format, nicotine strength, and flavour portfolio, primarily focusing on 6 mg and 9 mg strengths and traditional variants such as mint, wintergreen, and tobacco—reflecting a clear compliance-oriented approach.

Dec.22 by 2FIRSTS.ai

Illegal Disposable Vapes Still Sold in Nottingham Six Months After UK Ban: LBC Investigation

According to LBC, a follow-up investigation in Nottingham found that four out of 14 shops visited still sold illegal disposable vapes, six months after the UK Government’s ban took effect. Although fewer retailers appeared to be offering banned products compared with an earlier visit, illegal vapes remain available despite ongoing enforcement efforts.

Dec.03 by 2FIRSTS.ai

KT&G Nears ASF Acquisition, Preparing Wide Regional Nicotine Pouch Expansion

South Korean outlet nate reports that KT&G expects to finalize its acquisition of Nordic nicotine pouch maker ASF within this year. Beginning next year, the company plans to expand the business well beyond ASF’s current five Nordic markets to Europe, the Middle East, Africa, Asia and North America, supported by its cooperation framework with Altria.

Nov.25

Thai Police Raid Three Vape Warehouses in Chiang Mai, Seize 36,555 Items Worth US$200,000

Thai police raided three vape storage sites in Chiang Mai, arresting two women and seizing 36,555 vape items worth over ฿6.6 million（US$200,000）. Authorities estimate annual turnover at about ฿30 million（US$920,000） and are pursuing financial backers.